Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...